Earnings Preview: Amgen, Inc (NASDAQ:AMGN)
Monday, January 18, 2022 9:53 AM

Related Stories



Amgen, Inc (NASDAQ:AMGN), The world's biggest biotechnology company by sales,  is expected to release its fourth quarter earnings on Monday, January 25, 2010. In the last two quarters ending September 2009, the company's reported financial figures exceeded the market's consensus estimates by double digits.

The group's principal activities are to discover, develop, manufacture and market human therapeutics based on advances in cellular and molecular biology. It markets human therapeutic products in the areas of hematology, oncology and inflammation. The Group's key products include Aranesp(R) (darbepoetin alfa), EPOGEN(R) (Epoetin alfa), Neulasta(R) (pegfilgrastim), NEUPOGEN(R) (Filgrastim) and Enbrel(R) (etanercept) stimulate the production of red blood cells, for the treatment of anemia associated with chronic renal failure. Neulasta(R) and NEUPOGEN(R) selectively stimulate the production of neutrophils, one type of white blood cell, for treatment of infection in-patients undergoing myelosuppressive chemotherapy.

In the third quarter, the company generated revenue of $ 3.8 billion, down about 2% year over year revenue. Third quarter revenues were favorably impacted by tax considerations. Amgen's reported adjusted earnings per share increased 21% over the third quarter of 2008 to reach $1.49. Adjusted net income increased 16% to $1,518 million in the third quarter of 2009 compared to $1,308 million in the third quarter of 2008.

Analysts' estimates for the quarter ending December 2009 range from a low of $1.06 to a high of $1.28, compared to a consensus estimate of $1.166. According to Thomson Financial, for the fiscal quarter ending December 2009, the consensus EPS forecast has decreased over the past week from $1.208 to $1.166 (-3.48%) and decreased over the past month from $1.210 to $1.166 (-3.64%). Of the 23 analysts making quarterly forecasts, 1 raised and 8 lowered their forecast.

The downward revision in estimates is attributable to a variety of reasons such as higher taxes, higher operating costs, and increasing concern over the Food and Drug Administration's plan to re-examine the safety of Amgen's anemia drug. However, there were some positive developments in the fourth quarter which give ample scope for enthusiasm. In November, Amgen was honored with two 2009 Scrip Awards, winning for Best Overall Pipeline and for Best New Drug for Nplate?? (romiplostim). In December 2009, the company resolved EPO patent dispute with Roche. Amgen Inc is rumored to be planning to acquire the entire share capital of Savient Pharmaceuticals Inc, an East Brunswick-based pharmaceutical company.  

In the last one year, the stock has shed more than 2%. Currently the share is trading at $56.25, compared to 52 week range of $44.96 and $64.76. As a result, the company's share is currently trading at a reasonable PE of 12.52. I expect the PE to expand to around 15.5, so it looks good to make creeping acquisition of the stock.

My optimism stems from two sources. First, Amgen's denosumab, a product that may stop tumors from spreading beyond soft tissue could be used to treat osteoporosis in aging women. This could be a potential $14 billion revenue generator by end 2014. Second, the company's board of directors has authorized repurchases of up to an additional $5 billion in Amgen common stock.

 

Sponsors

Symbol :

Advertisement

Market news:

  • Iraq Kurdish leader: A uniter in a divided nation Nov 26, 2021 03:46 AM

    • In his five years as Iraq's president, Jalal Talabani has shown a remarkable ability to rise above the ethnic and religious divisions defining the country's political scene - sometimes at the expense of his own Kurdish identity.
    • But in rejecting the death sentence against Aziz - a Christian who was Saddam's longtime foreign minister - Talabani offered Iraq's small Christian minority a significant goodwill gesture at a time of deep uncertainty over its future in the wake of deadly attacks since 2003.
    • In polarized Iraq, most politicians press an unflinching sectarian or ethnic line - whether Sunni, Shiite or Kurdish - in a zero-sum game where another sect's win is often seen as your sect's loss.
      • Critics say Obama lagging on endangered species Nov 26, 2021 03:46 AM

        • WASHINGTON - Environmental groups are criticizing the Obama administration for what they say is a continuing backlog of plants and animals in need of protection under the Endangered Species Act.
        • The Fish and Wildlife Service says 251 species are candidates for endangered species protection, four more than a similar review last year found.
        • Environmental groups say that shows the Obama administration has done little to improve on what they consider a dismal record on endangered species under President George W. Bush.
          • Japan election sure to show opposition to US base Nov 26, 2021 03:35 AM

            • TOKYO - An election Sunday for the governor of a southern Japanese island where a controversial U.S. Marine base is located is likely to cause more problems for Japan's relations with key ally the United States, as both leading candidates want the facility off the island.
            • The U.S. Futenma air base has been located on Okinawa island since 1945, and residents have long complained it produces aircraft noise and crime.
            • A 2006 deal between the U.S. and Japan to relocate the base to a less crowded location on Okinawa has sunk into stalemate.
              • Gimmicks, long hours greet 'Black Friday' shoppers Nov 26, 2021 02:48 AM

                • After weeks of "Black Friday" sales pitches, the real thing is finally here.
                • Retailers are ushering in the traditional kickoff of the U.S. holiday shopping season on Friday with expanded hours, deep discounts and online deals to draw bargain-hungry shoppers.
                • In a bid to grab shoppers earlier, a number of stores including Old Navy, Toys R Us and Sears opened on Thanksgiving Day.
                  • Teenagers adrift in Pacific for 50 days reach land Nov 26, 2021 02:33 AM

                    • SUVA, Fiji - Three teenage boys who spent 50 days adrift in a tiny boat on the South Pacific walked ashore on shaky legs Friday, while hundreds of miles across the sea the people of their village celebrated what they called a miracle: their return from the dead.
                    • The trio - Samuel Pelesa and Filo Filo, both 15, and Edward Nasau, 14 - told rescuers they survived on rainwater they collected, a handful of coconuts, raw fish and a seagull that landed on their 12-foot (3.5-meter) -long aluminum boat.
                    • The boys set off Oct. 5 from their home island to one nearby.

                      More news


Advertisement

    Recent Estimates

AnalystFirm NameSymbolEPS Estimate
GEOXXXXX PAY$0.31
mrbilltraderXXXXX POT$1.15
XXXXXXXXXX OVTI$0.43
sam farahanXXXXX TECD$0.95
XXXXXXXXXX GSS$0.05
XXXXXXXXXX ABB$0.31
adfgafg ERTS($0.26)
XXXXXXXXXX SD$0.03
XXXXXXXXXX ATML$0.11
XXXXXXXXXX CBPO$0.32